Medical staff are dispensing vaccines at a medical institution in Seoul. [사진 출처 = 연합뉴스]– As the COVID-19 Vaccine Safety Committee released an analysis result that there is a causal relationship between menstrual disorders that occur after corona vaccination and vaccination, the likelihood of receiving compensation for damage in the future has increased.
Regarding the possibility of compensation for abnormal uterine bleeding after the COVID-19 vaccination on the 12th, the Korea Centers for Disease Control and Prevention (KCDC) said, “If causality or relevance is suggested by a publicly trusted institution such as the Vaccine Safety Committee, compensation will be paid after discussion with the Special Committee on Vaccination Damage Compensation. Or they may be included in the target of support.”
Accordingly, it is expected to discuss whether the causality of abnormal uterine bleeding is recognized in the near future. Abnormal uterine bleeding is when menstruation occurs irregularly outside the normal cycle, or the amount of bleeding exceeds the normal range even if the menstrual cycle is maintained.
Earlier, on the 11th, the Vaccine Safety Committee of the Korean Academy of Medicine published a study that showed a relationship between corona vaccine vaccination and abnormal uterine bleeding symptoms. It is through the presentation of the third research result that analyzed the adverse reactions after corona vaccination.
According to the published results, it was confirmed that the risk of abnormal uterine bleeding (excluding amenorrhea and delayed menstrual cycle) increased statistically significantly in women vaccinated.
Regardless of the type of vaccine, women who received the vaccine had a 1.42 times higher risk of abnormal uterine bleeding, such as frequent menstruation, than under normal conditions. Of the 108,000 patients with abnormal uterine bleeding symptoms, 31% were 16-29 years old, 28% 40-49 years old, and 23% 30-39 years old.
Earlier, many women complained of adverse menstrual reactions from the initial stage of vaccination against COVID-19, but the Korea Centers for Disease Control and Prevention did not include them in the report of adverse reactions.
However, as women’s anxiety grew as a series of related cases continued, the Korea Centers for Disease Control and Prevention (KCDC) improved the system so that abnormal uterine bleeding could be reported after a national audit in October last year.
“As a result of synthesizing the scientific evidence to date, the causal relationship between the COVID-19 vaccine and abnormal uterine bleeding is evaluated at an acceptable stage,” the committee explained.
However, this time, the researchers studied the risk of abnormal uterine bleeding, such as frequent menstruation for a relatively short period of time.
In addition, the researchers concluded that additional studies are needed in those who continue to experience abnormal uterine bleeding symptoms after vaccination.
[이하린 매경닷컴 기자]
[ⓒ 매일경제 & mk.co.kr, 무단전재 및 재배포 금지]
–
–
